Robert O Cotes1, Nisha K Fernandes2, Jennifer L McLaren3, Gregory J McHugo4, Stephen J Bartels3,5, Mary F Brunette3,5. 1. 1 Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine , Atlanta, Georgia . 2. 2 Meridian Psychiatric Partners, LLC, Chicago, Illinois. 3. 3 Department of Psychiatry, Geisel School of Medicine at Dartmouth , Lebanon, New Hampshire. 4. 4 The Dartmouth Insitute for Health Policy and Clinical Practice , Lebanon, New Hampshire. 5. 5 Bureau of Mental Health Services , Department of Health and Human Services, Concord, New Hampshire.
Abstract
OBJECTIVES: This study evaluated changes in cardiometabolic monitoring for children and adolescents who were prescribed an antipsychotic medication in a state mental health system before and after a quality improvement intervention. METHODS: The intervention included education for prescribers, auditing on metabolic monitoring, and feedback to mental health center leaders regarding their monitoring. Research staff extracted yearly data on cardiometabolic monitoring from randomly selected community mental health center records before and after the intervention. Pre- and postintervention changes in monitoring were assessed with chi-squared tests. RESULTS: Evidence of past year monitoring increased: for glucose 18.9%-42.1% (χ2 = 6.75, p < 0.001), for triglycerides 13.5%-31.0% (χ2 = 4.54, p = 0.033), for cholesterol 13.5%-33.1% (χ2 = 5.48, p = 0.019), and for weight 67.6%-84.1% (χ2 = 5.21, p = 0.022). Rates of monitoring for blood pressure and waist circumference increased but not significantly. In both years studied, weight was obtained most frequently and waist circumference was obtained least frequently. CONCLUSIONS: Monitoring rates significantly improved for four out of six parameters evaluated, but overall monitoring rates remained low at the end of the study period. Prescriber education with audit and feedback may improve cardiometabolic monitoring rates, but research is needed to evaluate barriers to monitoring in children.
OBJECTIVES: This study evaluated changes in cardiometabolic monitoring for children and adolescents who were prescribed an antipsychotic medication in a state mental health system before and after a quality improvement intervention. METHODS: The intervention included education for prescribers, auditing on metabolic monitoring, and feedback to mental health center leaders regarding their monitoring. Research staff extracted yearly data on cardiometabolic monitoring from randomly selected community mental health center records before and after the intervention. Pre- and postintervention changes in monitoring were assessed with chi-squared tests. RESULTS: Evidence of past year monitoring increased: for glucose 18.9%-42.1% (χ2 = 6.75, p < 0.001), for triglycerides 13.5%-31.0% (χ2 = 4.54, p = 0.033), for cholesterol 13.5%-33.1% (χ2 = 5.48, p = 0.019), and for weight 67.6%-84.1% (χ2 = 5.21, p = 0.022). Rates of monitoring for blood pressure and waist circumference increased but not significantly. In both years studied, weight was obtained most frequently and waist circumference was obtained least frequently. CONCLUSIONS: Monitoring rates significantly improved for four out of six parameters evaluated, but overall monitoring rates remained low at the end of the study period. Prescriber education with audit and feedback may improve cardiometabolic monitoring rates, but research is needed to evaluate barriers to monitoring in children.
Entities:
Keywords:
antipsychotic medications; cardiometabolic; metabolic monitoring; quality improvement; side effects
Authors: Robert O Cotes; Alex de Nesnera; Michael Kelly; Karen Orsini; Haiyi Xie; Greg McHugo; Stephen Bartels; Mary F Brunette Journal: Community Ment Health J Date: 2015-02-03
Authors: Terry T-K Huang; Laurel A Borowski; Benmei Liu; Deborah A Galuska; Rachel Ballard-Barbash; Susan Z Yanovski; Deborah H Olster; Audie A Atienza; Ashley Wilder Smith Journal: Am J Prev Med Date: 2011-07 Impact factor: 5.043
Authors: Jennifer L McLaren; Mary F Brunette; Gregory J McHugo; Robert E Drake; William B Daviss Journal: Psychiatr Serv Date: 2017-04-17 Impact factor: 3.084
Authors: Angie Mae Rodday; Susan K Parsons; Catherine Mankiw; Christoph U Correll; Adelaide S Robb; Bonnie T Zima; Tully S Saunders; Laurel K Leslie Journal: J Child Adolesc Psychopharmacol Date: 2015-04-28 Impact factor: 2.576
Authors: Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra Journal: JAMA Date: 2009-10-28 Impact factor: 56.272
Authors: Noah M Ivers; Jeremy M Grimshaw; Gro Jamtvedt; Signe Flottorp; Mary Ann O'Brien; Simon D French; Jane Young; Jan Odgaard-Jensen Journal: J Gen Intern Med Date: 2014-11 Impact factor: 5.128
Authors: Luís B Sardinha; Diana A Santos; Analiza M Silva; Anders Grøntved; Lars B Andersen; Ulf Ekelund Journal: PLoS One Date: 2016-02-22 Impact factor: 3.240
Authors: Lenneke Minjon; Ivona Brozina; Toine C G Egberts; Eibert R Heerdink; Els van den Ban Journal: Front Psychiatry Date: 2021-02-25 Impact factor: 4.157
Authors: Lenneke Minjon; Els van den Ban; Marloes T Bazelier; Arief Lalmohamed; Toine C G Egberts; Eibert R Heerdink Journal: J Child Adolesc Psychopharmacol Date: 2021-10-07 Impact factor: 2.576